Reports: Teva weighing sale of women’s health unit

JERUSALEM — Teva Pharmaceuticals is considering a sale of its women’s health unit, which could earn the company $2 billion in proceeds, according to multiple news reports.

Teva is reportedly working with Morgan Stanley to find a buyer and could begin the process as early as May, reported Israeli newspaper Globes.

Teva acquired the women’s health division from Merck KGaA’s Merck Serono in 2010.